ERA SPECIFIC BIOCHEMICAL RECURRENCE-FREE SURVIVAL FOLLOWING RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER
- 1 August 2001
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 166 (2), 416-419
- https://doi.org/10.1016/s0022-5347(05)65955-1
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer?JAMA, 2000
- Declining Rates of Extracapsular Extension After Radical Prostatectomy: Evidence for Continued Stage MigrationJournal of Clinical Oncology, 1999
- Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high gleason grade prostate carcinomaCancer, 1998
- National trends in the epidemiology of prostate cancer, 1973 to 1994: evidence for the effectiveness of prostate-specific antigen screeningUrology, 1998
- Influence of prostate-specific antigen testing on the spectrum of patients with prostate cancer undergoing radical prostatectomy at a large referral practice.Mayo Clinic Proceedings, 1998
- Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional updatePublished by American Medical Association (AMA) ,1997
- The National Cancer Data Base report on longitudinal observations on prostate cancerCancer, 1996
- The role of increasing detection in the rising incidence of prostate cancerPublished by American Medical Association (AMA) ,1995
- Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screeningPublished by American Medical Association (AMA) ,1993
- Impotence Following Radical Prostatectomy: Insight Into Etiology and PreventionJournal of Urology, 1982